Jump to ContentJump to Main Navigation
Show Summary Details

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.


IMPACT FACTOR increased in 2015: 3.017
Rank 5 out of 30 in category Medical Laboratory Technology in the 2014 Thomson Reuters Journal Citation Report/Science Edition

SCImago Journal Rank (SJR) 2015: 0.873
Source Normalized Impact per Paper (SNIP) 2015: 0.982
Impact per Publication (IPP) 2015: 2.238

249,00 € / $374.00 / £187.00*

Online
ISSN
1437-4331
See all formats and pricing

 


Select Volume and Issue

Issues

30,00 € / $42.00 / £23.00

Get Access to Full Text

IFCC Primary Reference Procedures for the Measurement of Catalytic Activity Concentrations of Enzymes at 37°C. Part 7. Certification of Four Reference Materials for the Determination of Enzymatic Activity of γ-Glutamyltransferase, Lactate Dehydrogenase, Alanine Aminotransferase and Creatine Kinase according to IFCC Reference Procedures at 37°C

L. Siekmann / R. Bonora / C. A. Burtis / F. Ceriotti / P. Clerc-Renaud / G. Férard / C. A. Ferrero / J.-C. Forest / P. F. H. Franck / F.-J. Gella / W. Hoelzel / P. J. Jørgensen / T. Kanno / A. Kessner / R. Klauke / N. Kristiansen / J.-M. Lessinger / T. P. J. Linsinger / H. Misaki

Citation Information: Clinical Chemistry and Laboratory Medicine. Volume 40, Issue 7, Pages 739–745, ISSN (Print) 1434-6621, DOI: 10.1515/CCLM.2002.127, June 2005

Publication History

Published Online:
2005-06-01

Abstract

This paper is the seventh in a series dealing with reference procedures for the measurement of catalytic activity concentrations of enzymes at 37°C and the certification of reference preparations. Other parts deal with:

Part 1. The Concept of Reference Procedures for the Measurement of Catalytic Activity Concentrations of Enzymes; Part 2. Reference Procedure for the Measurement of Catalytic Concentration of Creatine Kinase; Part 3. Reference Procedure for the Measurement of Catalytic Concentration of Lactate Dehydrogenase; Part 4. Reference Procedure for the Measurement of Catalytic Concentration of Alanine Aminotransferase; Part 5. Reference Procedure for the Measurement of Catalytic Concentration of Aspartate Aminotransferase; Part 6. Reference Procedure for the Measurement of Catalytic Concentration of γ-Glutamyltransferase. A document describing the determination of preliminary reference values is also in preparation.

The certification of the catalytic activity concentrations as determined by the recently elaborated IFCC primary reference methods at 37°C of four enzyme preparations, namely IRMM/IFCC 452 γ-glutamyltransferase), IRMM/IFCC 453 (lactate dehydrogenase 1), IRMM/IFCC 454 (alanine aminotransferase) and IRMM/IFCC 455 (creatine kinase) is described. Homogeneity data were derived from previous results. Stability was assessed using recently obtained data as well as data from previous stability studies. The collaborative study for value assignment was performed under a strict quality control scheme to ensure traceability to the primary reference method. Uncertainty of the materials was assessed in compliance with the Guide to the Expression of Uncertainty in Measurement. The certified values obtained at 37°C are 1.90 μkat/l ± 0.04 μkat/l (114.1 U/l ± 2.4 U/l), for γ-glutamyltransferase, 8.37 μkat/l ± 0.12 μkat/l (502 U/l ± 7 U/l), for lactate dehydrogenase 1, 3.09 μkat/l ± 0.07 μkat/l (186 U/l ± 4 U/l), for alanine aminotransferase and 1.68 μkat/l ± 0.07 μkat/l (101 U/l ± 4 U/l), for creatine kinase. The materials are intended for internal quality control as well as for the evaluation of test systems as required by recent European Union legislation. Furthermore, the materials can be used to transfer accuracy from a reference method to a routine procedure provided the procedures exhibit the same analytical specificity and the certified materials are commutable.

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Donald Sédric Tala, Donatien Gatsing, Siméon Pierre Chegaing Fodouop, Charles Fokunang, Fabrice Kengni, and Merline Namekong Djimeli
Asian Pacific Journal of Tropical Biomedicine, 2015, Volume 5, Number 4, Page 310
[2]
M. Kappler, C. Espach, A. Schweiger-Kabesch, T. Lang, D. Hartl, A. Hector, C. Glasmacher, and M. Griese
Alimentary Pharmacology & Therapeutics, 2012, Volume 36, Number 3, Page 266
[3]
Angel Díaz-Lagares, Estíbaliz Alegre, Ainhoa Arroyo, María González-Cao, Maria E. Zudaire, Santiago Viteri, Salvador Martín-Algarra, and Alvaro González
Tumor Biology, 2011, Volume 32, Number 6, Page 1155
[4]
Jouni Karppi, Tarja Nurmi, Sudhir Kurl, Tiina H. Rissanen, and Kristiina Nyyssönen
Atherosclerosis, 2010, Volume 209, Number 2, Page 565
[5]
Gerhard Schumann, Rainer Klauke, Francesca Canalias, Steffen Bossert-Reuther, Paul F.H. Franck, F.-Javier Gella, Poul J. Jørgensen, Dongchon Kang, Jean-Marc Lessinger, Mauro Panteghini, and Ferruccio Ceriotti
Clinical Chemistry and Laboratory Medicine, 2011, Volume 49, Number 9
[7]
Amal M. Moustafa and Vivian Boshra
Journal of Molecular Histology, 2011, Volume 42, Number 3, Page 217
[8]
Franca Pagani, Roberto Bonora, and Mauro Panteghini
Clinical Chemistry and Laboratory Medicine, 2003, Volume 41, Number 7

Comments (0)

Please log in or register to comment.